AI assistant
Paragon Banking Group PLC — Director's Dealing 2018
Aug 23, 2018
4701_dirs_2018-08-23_d2e0f442-1d3f-425c-8ae2-21cb2e984fe2.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7451Y
Paragon Banking Group PLC
23 August 2018
Paragon Banking Group PLC:
Director Shareholding
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Alan Keith Fletcher
2
Reason for the notification
a)
Position/status
Non-executive Director (PDMR)
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Paragon Banking Group PLC
b)
LEI
213800S1TDKIB1IUTS72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of £1.00 each in Paragon Banking Group PLC
GB00B2NGPM57
b)
Nature of the transaction
Disposal of 20,000 shares.
Following this transaction, Alan Fletcher remains interested in 30,000 Ordinary Shares of £1.00 each in Paragon Banking Group PLC.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £4.9240 | 10,000 |
| £4.9201 | 10,000 |
d)
Aggregated information
- Aggregated volume
- Price
20,000
£4.92205
e)
Date of the transaction
2018/08/22
f)
Place of the transaction
London Stock Exchange, Main Market (XLON)
Enquiries:
Pandora Sharp, Company Secretary
0121 712 2075
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHEXLFLVVFEBBL